{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:54:02Z","timestamp":1770378842021,"version":"3.49.0"},"reference-count":20,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Was ist neu?<\/jats:title><jats:p>\n            Epidemiologie Das Still-Syndrom kann sich vom Kindes- bis ins h\u00f6here Erwachsenenalter manifestieren \u2013 mit jeweils leicht unterschiedlicher klinischer Auspr\u00e4gung.<\/jats:p><jats:p>\n            Pathogenese Das Still-Syndrom ist eine autoinflammatorische Erkrankung unklarer \u00c4tiologie, bei der pathogenetisch das angeborene Immunsystem in Form einer Aktivierung von neutrophilen Granulozyten mit Freisetzung von pro-inflammatorischen Zytokinen IL1, -6, -18, und Typ-1-Interferonen eine zentrale Rolle einnehmen.<\/jats:p><jats:p>\n            Diagnose und Differenzialdiagnose In der k\u00fcrzlich erschienenen DGRh-S2e-Leitlinie zum adulten Still-Syndrom (AOSD) wird empfohlen, die Diagnose anhand der charakteristischen Symptomkonstellation aus u.a. intermittierendem Fieber, Exanthem, Arthralgien\/Arthritis nach Ausschluss von Infektionen, Neoplasien und anderen rheumatologischen Erkrankungen zu stellen. Die Erf\u00fcllung der Yamaguchi-Klassifikationskriterien kann hierbei die Diagnose unterst\u00fctzen.<\/jats:p><jats:p>\n            Komplikationen Relevante Komplikationen mit Verschlechterung der Prognose sind insbesondere eine Perimyokarditis, eine vielgestaltige Lungenbeteiligung und das Makrophagenaktivierungssyndrom (MAS, auch als sekund\u00e4re h\u00e4mophagozytische Lymphohistiozytose [HLH] bezeichnet). Beim MAS-HLH kommt es zum Zytokinsturm und zu einer Multiorganbeteiligung mit Zytopenien.<\/jats:p><jats:p>\n            Therapie Nach klinischer Aktivit\u00e4tseinsch\u00e4tzung wird eine Therapie mit Glukokortikoiden und Methotrexat oder Ciclosporin, bei h\u00f6herer Aktivit\u00e4t auch mit dem IL1-Rezeptorantagonisten Anakinra, dem IL1\u03b2-Antik\u00f6rper Canakinumab oder dem IL6-Rezeptorantik\u00f6rper Tocilizumab empfohlen. Bei hoher Krankheitsaktivit\u00e4t kann gem\u00e4\u00df den Leitlinien auch eine prim\u00e4re Therapie mit Anakinra oder Canakinumab erfolgen. Die Zulassungssituation ist hierbei jeweils zu beachten. Therapeutisch sind in der vital bedrohlichen Situation eines MAS-HLH neben supportiven Intensivma\u00dfnahmen der Einsatz hochdosierter Glukokortikoide, in Kombination mit den genannten Biologika, und ggf. auch Etoposid-haltige Therapieregime in Anlehnung an die Behandlungsempfehlungen anderer HLH-Erkrankungen notwendig.<\/jats:p>","DOI":"10.1055\/a-2000-3446","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T22:46:05Z","timestamp":1685573165000},"page":"788-792","source":"Crossref","is-referenced-by-count":3,"title":["Aktuelles zum adulten Still-Syndrom: Diagnose, Therapiekonzepte und Leitlinie"],"prefix":"10.1055","volume":"148","author":[{"given":"Stefan","family":"Vordenb\u00e4umen","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Rheumatologie, St. Elisabeth-Hospital Meerbusch-Lank, Meerbusch-Lank, Deutschland"},{"name":"Poliklinik f\u00fcr Rheumatologie, Universit\u00e4tsklinikum D\u00fcsseldorf, D\u00fcsseldorf, Deutschland"},{"name":"Poliklinik, Funktionsbereich und Hiller Forschungszentrum f\u00fcr Rheumatologie, Universit\u00e4tsklinikum D\u00fcsseldorf, Medizinische Fakult\u00e4t, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf, D\u00fcsseldorf, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[{"name":"Helios Fachklinik Vogelsang-Gommern, Klinik f\u00fcr Rheumatologie, Kooperationspartner der Otto-von-Guericke Universit\u00e4t Magdeburg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.3390\/jcm11226703","article-title":"The Spectrum of Still\u2019s Disease: A Comparative Analysis of Phenotypic Forms in a Cohort of 238 Patients","volume":"11","author":"PA Neau","year":"2022","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/0215kv","article-title":"Adult-onset Still\u2019s disease with elderly onset, results from a multicentre study","author":"Cola Di I","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10067-021-05929-8","article-title":"Impact of smoking habit on adult-onset Still\u2019s disease prognosis, findings from a multicentre observational study","volume":"41","author":"P Ruscitti","year":"2022","journal-title":"Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102793","DOI":"10.1016\/j.jaut.2022.102793","article-title":"Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still\u2019s disease","volume":"127","author":"Y Ma","year":"2022","journal-title":"J Autoimmun"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1038\/s41467-022-34560-7","article-title":"Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still\u2019s disease pathogenesis","volume":"13","author":"J Jia","year":"2022","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"881431","DOI":"10.3389\/fmed.2022.881431","article-title":"Adult-onset Still\u2019s disease: A disease at the crossroad of innate immunity and autoimmunity","volume":"9","author":"S Rao","year":"2022","journal-title":"Front Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00393-022-01276-4","article-title":"DGRh-S2e-Leitlinie: Diagnostik und Therapie des adulten Still-Syndroms (AOSD)","volume":"81","author":"S Vordenb\u00e4umen","year":"2022","journal-title":"Z F\u00fcr Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00393-022-01277-3","article-title":"Leitlinienreport zur DGRh-S2e-Leitlinie Diagnostik und Therapie des adulten Still-Syndroms (AOSD)","volume":"81","author":"S Vordenb\u00e4umen","year":"2022","journal-title":"Z F\u00fcr Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-022-01293-3","article-title":"Adultes Still-Syndrom: Diagnostik und Therapie unter Ber\u00fccksichtigung der neuen DGRh (Deutsche Gesellschaft f\u00fcr Rheumatologie)-S2e-Leitlinie","author":"S Vordenb\u00e4umen","year":"2022","journal-title":"Z F\u00fcr Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e30152","DOI":"10.1097\/MD.0000000000030152","article-title":"Diagnostic utility of clinical characteristics, laboratory tests, and serum ferritin in diagnosis of adult-onset Still disease","volume":"101","author":"I Sagy","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.3390\/jcm11082232","article-title":"Strategy and Challenges of Paraclinical Examinations in Adult-Onset Still\u2019s Disease","volume":"11","author":"N Poursac","year":"2022","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-022-00516-y","article-title":"A Streamlined Diagnostic Process Improved the Outcomes of Patients with Adult-Onset Still\u2019s Disease: A Single-Center Retrospective Observational Study","author":"SH Chang","year":"2022","journal-title":"Rheumatol Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.3390\/jcm11175012","article-title":"Evaluation of Glycosylated Ferritin in Adult-Onset Still\u2019s Disease and Differential Diagnoses","volume":"11","author":"A Guerber","year":"2022","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e29970","DOI":"10.1097\/MD.0000000000029970","article-title":"Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still\u2019s disease: A STROBE-Compliant prospective observational study","volume":"101","author":"K Daghor Abbaci","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS","volume":"149","author":"CI van der Made","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"603389","DOI":"10.3389\/fimmu.2020.603389","article-title":"Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still\u2019s Disease: Similarities and Differences","volume":"11","author":"J Meng","year":"2021","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"102980","DOI":"10.1016\/j.jaut.2022.102980","article-title":"Comprehensive description of adult-onset Still\u2019s disease after COVID-19 vaccination","volume":"134","author":"P Palassin","year":"2023","journal-title":"J Autoimmun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"989777","DOI":"10.3389\/fmed.2022.989777","article-title":"Rare, rarer, lung involvement in adult-onset Still\u2019s disease: A mini-review","volume":"9","author":"JF Nies","year":"2022","journal-title":"Front Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/1o41c8","article-title":"A retrospective analysis of colchicine in combination with NSAIDs therapy in patients with systemic form of adult-onset Still\u2019s disease with serositis","author":"V Myachikova","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/BTT.S290329","article-title":"Progress in Biological Therapies for Adult-Onset Still\u2019s Disease","volume":"16","author":"P Galozzi","year":"2022","journal-title":"Biol Targets Ther"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2000-3446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T22:50:13Z","timestamp":1685573413000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2000-3446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,5,31]]},"published-print":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2000-3446","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}